Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02643849 · ClinicalTrials.gov registry record · NA

Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men

A NA study of Urinary Retention, sponsored by SRS Medical.

Completed
Registry status
NA
Development phase
107
Enrollment target
6
Study locations

NCT02643849: Completed NA study of Urinary Retention, sponsored by SRS Medical.

NCT02643849 is a NA study of Urinary Retention that has completed, run by SRS Medical. The registered enrollment target is 107 participants, below the 130-participant average among 11 other Urinary Retention trials with a reported enrollment target (18% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02643849, a NA study of Urinary Retention, has completed, sponsored by SRS Medical.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target
6
Study locations

Study Summary

The Spanner is being evaluated for use to manage voiding dysfunction and lower urinary tract symptoms in subjects to achieve bladder drainage in men unfit for other treatments.

Primary Outcome

To determine the percentage of subjects who achieved adequate bladder drainage over 90 days, defined as a PVR of ≤150 ml.

Conditions Studied

Interventions

  • DEVICE The Spanner Temporary Prostatic Stent

Study Locations (6)

Florida

  • Atlantic Urology - Daytona Beach
  • Advanced Urology Specialists - Oxford
  • Urology Specialists of West Florida - Palm Harbor
  • Pinellas Urology Inc - South Pasadena

Massachusetts

  • Greater Boston Urology - Hingham

New York

  • Brooklyn Urology Research Group - Brooklyn

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2016-08
Est. Completion 2019-02
Phase NA
SRS Medical

1 total trials

What the finished NCT02643849 record still lists

NCT02643849 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 130-participant average among 11 other Urinary Retention trials with a reported enrollment target (18% lower).

The record links to 1 condition, with Urinary Retention appearing as the primary indexed condition, and to 1 intervention - of which The Spanner Temporary Prostatic Stent is the first listed.

NCT02643849 lists 6 locations in 3 states (Florida, Massachusetts, New York).

Frequently Asked Questions

What is clinical trial NCT02643849 about?

NCT02643849 is a clinical study titled "Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men". The Spanner is being evaluated for use to manage voiding dysfunction and lower urinary tract symptoms in subjects to achieve bladder drainage in men unfit for other treatments.

What is the current status of trial NCT02643849?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2016-08. Estimated completion is 2019-02.

What conditions does trial NCT02643849 study?

This clinical trial studies the following conditions: Urinary Retention.

What interventions are being tested in trial NCT02643849?

The interventions under investigation include: The Spanner Temporary Prostatic Stent (DEVICE).

Who is sponsoring clinical trial NCT02643849?

This trial is sponsored by SRS Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02643849 being conducted?

This trial has 6 study locations across Florida, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Retention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02643849's enrollment target sits among peer trials

107 4th of 11 higher than 8 of 11 other Urinary Retention trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Urinary Retention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491668 · 107 participants

    Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

  • NCT06041594 · 107 participants · NA

    Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

  • NCT06081426 · 107 participants · NA

    Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

  • NCT06527599 · 107 participants · NA

    Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02643849, the US trial registry maintained by the National Library of Medicine. NCT02643849 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.